Data from the Gore ASSURED Clinical Study demonstrated 100 percent closure success at six months
Jun 4, 2019
CE Mark supported by data from the Gore ASSURED Clinical Study, demonstrating 100 percent closure success
Oct 2, 2019
New addition to GORE® CARDIOFORM Occluder family is designed to treat larger atrial septal defects by adapting to the patient’s anatomy for a permanent and safe closure
Sep 26, 2017
W. L. Gore & Associates (Gore) today announced a favorable ruling involving the GORE® HELEX® Septal Occluder.
Aug 5, 2013